Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
New eye drops could prevent vision loss after retinal vein occlusion

New eye drops could prevent vision loss after retinal vein occlusion

Older people less likely to share memories of their past experiences

Older people less likely to share memories of their past experiences

Remodeling may make neurons more prone to Alzheimer's disease

Remodeling may make neurons more prone to Alzheimer's disease

New model helps study human hippocampal neurons

New model helps study human hippocampal neurons

Study highlights a complex and under-recognized form of dementia

Study highlights a complex and under-recognized form of dementia

Researchers provide mechanistic insight into protein co-aggregation in Alzheimer's disease

Researchers provide mechanistic insight into protein co-aggregation in Alzheimer's disease

Pediatric patients more resilient against COVID-19 compared to adults

Pediatric patients more resilient against COVID-19 compared to adults

New steroid compounds from deep-water starfish show anticancer activity

New steroid compounds from deep-water starfish show anticancer activity

Study shows why ApoE4 increases risk of Alzheimer's disease

Study shows why ApoE4 increases risk of Alzheimer's disease

Researchers identify new molecules to study specific glial cells integral to synapses

Researchers identify new molecules to study specific glial cells integral to synapses

Researchers study unique needs of caregivers of persons with ADRD during COVID-19

Researchers study unique needs of caregivers of persons with ADRD during COVID-19

Parkinson's disease breakthrough seen in mouse model

Parkinson's disease breakthrough seen in mouse model

Study examines statin use among nursing home residents nearing the end of life

Study examines statin use among nursing home residents nearing the end of life

Tau protein modifications may be linked to heterogeneity in Alzheimer’s disease

Tau protein modifications may be linked to heterogeneity in Alzheimer’s disease

Hungarian physician to receive the Körber Prize for European Science 2020

Hungarian physician to receive the Körber Prize for European Science 2020

Newly discovered Alzheimer's gene may drive earliest brain changes

Newly discovered Alzheimer's gene may drive earliest brain changes

Specific changes in DNA affect the existence and amount of gut bacteria, study finds

Specific changes in DNA affect the existence and amount of gut bacteria, study finds

New study may provide a 'playlist' for testing brain disorders

New study may provide a 'playlist' for testing brain disorders

Brain-transportable soy derivate reduces memory degradation in mice

Brain-transportable soy derivate reduces memory degradation in mice

Researchers caution use of chloroquine therapy for patients at higher risk of heart rhythm abnormalities

Researchers caution use of chloroquine therapy for patients at higher risk of heart rhythm abnormalities

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.